Published: 2025-01-13

Clinical Management Recommendations

The Role of Image-Guided Superficial Radiation Therapy in the Treatment of Nonmelanoma Skin Cancer

Danny Zakria, Joshua Burshtein, Milaan Shah, Clay Cockerell, Gary Goldenberg, Mark Nestor, Deborah Sarnoff, Susan Weinkle, Darrell Rigel, James Q. Del Rosso
| DOI https://doi.org/10.25251/skin.9.1.1

Page 2042-2054

In-Depth Reviews

Original Research

Research Letters

Comparing Improvements in Biopsy Decision Making with Electrical Impedance Spectroscopy Between US and German Dermatologists

Danny Zakria, Nicholas Brownstone, Milaan Shah, Joshua Burshtein, Lauren DeBusk, Angela Rosenberg, Darrell Rigel
| DOI https://doi.org/10.25251/skin.9.1.5

Page 2082-2086

Brief Articles

Acute Generalized Exanthematous Pustulosis after Oral Antihistamine

Hannah Riva, Martin Giandoni, Frank Celis, Cynthia Reyes Barron
| DOI https://doi.org/10.25251/skin.9.1.13

Page 2116-2119

Vulvar Porocarcinoma with Inguinal Nodal Recurrence: A Case Report

Hannah J Porter, Nadeem Marghoob, Hayden Christensen, Matthew Dinehart, Conor O'Neill, Mark Wick, Laura Greene, Christine H Weinberger
| DOI https://doi.org/10.25251/skin.9.1.15

Page 2125-2129

SKINmages: Clinical Images in Dermatology

Elastic Garment Bands in an Adult

Sara Attari, Margaret Newsome, Matthew Belcher
| DOI https://doi.org/10.25251/skin.9.1.20

Page 2149-2151

Poster Presentations from FC24 Dermatology Conference®: Psoriasis

Atopic Dermatitis

Long-Term Efficacy and Safety of Lebrikizumab Is Maintained in Patients With Moderate-to-Severe ​ Atopic Dermatitis: Results Up to 3 Years From ADjoin

Emma Guttman-Yassky, Alan Irvine, Eric Simpson, Melinda Gooderham, Stephan Weidinger, Lynda Spelman, Jonathan Silverberg, Heidi Crane, Hany Elmaraghy, Louise DeLuca-Carter, Maria Lucia Buziqui Piruzeli, Chaoran Hu, Evangeline Pierce, Helena Agell, Diamant Thaçi
| DOI https://doi.org/10.25251/skin.9.supp.510

Page s510

Lebrikizumab Confirms a Consistent Safety Profile in Adults and Adolescents With Moderate-to-Severe Atopic Dermatitis: ​ Data From 11 Trials With Over 3000 Patient-Years of Exposure

Linda Stein Gold, Eric Simpson, Diamant Thaçi, Alan Irvine, Marjolein de Bruin-Weller, Gaia Gallo, Maria Lucia Buziqui Piruzeli, Hany Elmaraghy, Jinglin Zhong, Sonia Montmayeur, Ruth Coll, Mark G. Lebwohl
| DOI https://doi.org/10.25251/skin.9.supp.511

Page s511

Lebrikizumab Improves Atopic Dermatitis and ​Quality of Life in Patients With Moderate-to-Severe Atopic Dermatitis Previously Treated With Dupilumab: ​ Results From the ADapt Trial

Jonathan Silverberg, Lindsay Ackerman, Jerry Bagel, Linda Stein Gold, Andrew Blauvelt, David Rosmarin, Raj Chovatiya, Matthew Zirwas, Gil Yosipovitch, Jill Waibel, Jenny E. Murase, Ben Lockshin, Jamie Weisman, Amber Reck Atwater, Jennifer Proper, Maria Silk, Evangeline Pierce, Maria Lucia Buziqui Piruzeli, Sonia Montmayeur, Christopher Schuster, Jinglin Zhong, Maria Jose Rueda, Sreekumar Pillai, Eric Simpson
| DOI https://doi.org/10.25251/skin.9.supp.512

Page s512

Assessing Post-Inflammatory Pigmentation in Atopic Dermatitis: Reliability of the PDCA-Derm™

Andrew Alexis, Evangeline Pierce, Andrea Cohee, Sylvia Su, Amber Reck Atwater, Maria Jose Rueda, Sonia Montmayeur, Brittany Klooster, Caitlyn Lowe, Jonathan Silverberg
| DOI https://doi.org/10.25251/skin.9.supp.514

Page s514

Lebrikizumab Improves Atopic Dermatitis in Adult and Adolescent Patients With Skin of Color: 16-Week Results From the ADmirable Study

Andrew Alexis, Ali Moiin, Jill Waibel, Paul Wallace, David Cohen, Vivian Laquer, Pearl Kwong, Amber Reck Atwater, Jennifer Proper, Maria Silk, Evangeline Pierce, Sreekumar Pillai, Maria Jose Rueda, Angela Moore
| DOI https://doi.org/10.25251/skin.9.supp.515

Page s515

Achieving Depth of Response in Skin Clearance and Itch Relief With Lebrikizumab is Associated With Minimal Impact of Atopic Dermatitis on Quality of Life

Raj Chovatiya, Eric Simpson, Tilo Biedermann, Leon Kircik, Vivian Y. Shi, Ignasi Figueras-Nart, Marta Casillas, Gaia Gallo, Yuxin  Ding, Hong  Zhang, Evangeline  Pierce, Helena  Agell, Christian  Vestergaard
| DOI https://doi.org/10.25251/skin.9.supp.516

Page s516

Lebrikizumab vs Other Systemic Monotherapies for Moderate to Severe Atopic Dermatitis: Network Meta-analysis of Short-term Efficacy

Jonathan Silverberg, Thomas Bieber, Amy Paller, Masahiro Kamata, Luis Puig, Marni Wiseman, Khaled Ezzedine, Peter Foley, Martin Dossenbach, Buelent Akmaz, Marta Casillas, Andrei Karlsson, Raj Chovatiya
| DOI https://doi.org/10.25251/skin.9.supp.517

Page s517

Race and Ethnicity Related Variations in the Social Impact and Stigma of Atopic Dermatitis Among Adults With AD: US-based Patient Survey

Candrice Heath, Bryan Dosono, Vivian Y. Shi, Jennifer Soung, Wendy Smith Begolka, Amber Reck Atwater, Evangeline Pierce, Elizabeth Bacci, Julia Correll, Melissa Constantine, Raj Chovatiya
| DOI https://doi.org/10.25251/skin.9.supp.518

Page s518

Comparative Efficacy of Lebrikizumab, Dupilumab, and Tralokinumab in Maintaining Treatment Response in Atopic Dermatitis at Varying Treatment Continuance Rates

Jonathan Silverberg, Alan Irvine, Peter Foley, James Del Rosso, Luis Puig, Linda Stein Gold, Martin Dossenbach, Marta Casillas, Gaia Gallo, Buelent Akmaz, Kim Rand
| DOI https://doi.org/10.25251/skin.9.supp.519

Page s519

Alopecia

Baricitinib Achieved Complete/Near Complete Scalp Coverage in SALT Score ≤20 Responders: 52-Week Findings From BRAVE-AA Trials

Justin Ko, Amy McMichael, Maria Hordinsky, Thierry Passeron, Yutaka Shimomura, Samuel Ogwu, Rukhsar Chughtai, Najwa Somani, Brett King
| DOI https://doi.org/10.25251/skin.9.supp.520

Page s520

Evidence-Based Data on How Long to Treat to Achieve Treatment Response With Baricitinib in Severe Alopecia Areata

Brett King, Maryanne Senna, Manabu Ohyama, Rodney Sinclair, Najwa Somani, Yves Dutronc, Na Lu, Yun-Fei Chen, Jakub P. Jedynak, Andrew Buchanan, Bianca M. Piraccini
| DOI https://doi.org/10.25251/skin.9.supp.521

Page s521

Characterizing Loss of Response Occurring in a Small Number of Patients During 3 Years of Long-Term Maintenance Therapy with Baricitinib 4-mg: Results From BRAVE-AA1 and -AA2 Trials

Maryanne Senna, Susan Taylor, Bianca M. Piraccini, Jerry Shapiro, Najwa Somani, Jakub P. Jedynak, Samuel Ogwu, Andrew Buchanan, Brittany Craiglow, Manabu Ohyama
| DOI https://doi.org/10.25251/skin.9.supp.522

Page s522

Understanding the Experience of Healthcare Access and Health-Related Impacts among Individuals with Alopecia Areata

Candrice R. Heath, Lisa Anderson, Shamsha Damani, Elizabeth D. Bacci, Andrew Buchanan, Julia R. Correll, Evangeline J. Pierce, Melissa L. Constantine, Beth Mitchell, Raj Chovatiya
| DOI https://doi.org/10.25251/skin.9.supp.523

Page s523

Miscellaneous

Post-Hoc Analyses Support Efficacy of Lebrikizumab in Patients With Moderate-to-Severe Uncontrolled Eosinophilic Asthma and Prior Exacerbations

Jonathan Corren, Stanley J. Szefler, Ellen Sher, Phillip Korenblat, Weily Soong, Nicola A. Hanania, Gary Berman, Guy Brusselle, Ralph Zitnik, Chitra R. Natalie, Kimberly Siu, Wen-Shuo Wu, Meihua Qiao, Peter Lio, April W. Armstrong
| DOI https://doi.org/10.25251/skin.9.supp.524

Page s524